NanoEntek ExTransfection™ Capillary-Based Electroporation System

Overview

The NanoEntek ExTransfection™ is a third-generation, capillary-based electroporation system engineered for high-efficiency, low-cytotoxicity nucleic acid and ribonucleoprotein (RNP) delivery into sensitive mammalian cell types. Unlike conventional cuvette-based electroporators that generate non-uniform electric fields and localized pH shifts, the ExTransfection™ employs a precision-machined fused-silica capillary chamber with integrated electrode geometry optimized for homogeneous field distribution and minimal joule heating. This architecture enables transient, reversible membrane permeabilization under tightly controlled voltage, pulse duration, and waveform parameters—critical for preserving viability in primary T cells, iPSCs, hematopoietic stem cells (HSCs), and other electroporation-refractory populations. Designed for both discovery-phase research and scalable process development, the system operates within a regulatory-compliant framework aligned with ISO 13485 quality management principles and supports audit-ready documentation for GLP and early-stage GMP workflows.

Key Features

• Capillary Electroporation Chamber: Replaces traditional cuvettes with a 100–200 µL volume, chemically inert fused-silica capillary; ensures uniform electric field distribution (<±3% spatial variation), stable intra-chamber pH during pulsing, and reduced arcing risk—even at high-voltage protocols required for RNP delivery.
• Intelligent Parameter Matrix: Pre-validated library of >300 electroporation protocols, curated from peer-reviewed publications and internal benchmarking across 12+ human and murine primary cell types; includes empirically optimized settings for Cas9-gRNA RNP, mRNA, siRNA, and plasmid DNA delivery.
• Three-Step Workflow Architecture: Integrated sample loading → programmable pulse execution → post-pulse incubation trigger; eliminates manual transfer steps between electroporation and recovery, minimizing shear stress and contamination risk.
• Automated Calibration & Diagnostics: On-board impedance monitoring before each run confirms electrode integrity and buffer conductivity; real-time pulse logging captures actual delivered voltage, current, and time constants for full traceability.
• GMP-Ready Data Integrity: Compliant with FDA 21 CFR Part 11 requirements via optional electronic signature module, audit trail logging, and user-access-controlled parameter locking—enabling use in preclinical cell therapy process development.

Sample Compatibility & Compliance

The ExTransfection™ demonstrates validated performance across a broad spectrum of difficult-to-transfect cells—including human CD34+ HSCs, PBMC-derived T cells, mouse neural stem cells, and organoid-derived epithelial cells—without requiring chemical enhancers or carrier reagents. All protocols are compatible with standard electroporation buffers (e.g., P3 Primary Cell Solution, SF Cell Line Solution) and support serum-containing or serum-free recovery media. The instrument’s hardware and firmware design conform to IEC 61010-1 (Safety Requirements for Electrical Equipment for Measurement, Control, and Laboratory Use) and electromagnetic compatibility standards per EN 61326-1. Manufacturing occurs in a South Korean facility certified to ISO 13485:2016, with full material traceability and change control documentation available upon request.

Software & Data Management

The ExTransfection™ Control Suite (v4.2+) provides a secure, role-based interface for protocol selection, parameter customization, and run execution. Each session generates an encrypted .epx file containing raw pulse waveforms, impedance profiles, environmental sensor data (temperature, humidity), and user metadata. Export options include CSV (for statistical analysis in R or Python), PDF (for lab notebook archiving), and XML (for LIMS integration). Audit trails record all parameter modifications, user logins, and firmware updates with timestamps and digital signatures. Optional cloud synchronization enables cross-site protocol harmonization while maintaining on-premise data sovereignty per institutional IT policies.

Applications

• CRISPR-Cas9 and base editor RNP delivery into primary immune cells for CAR-T and TCR-T engineering
• mRNA transfection of dendritic cells for personalized cancer vaccine development
• siRNA knockdown in patient-derived xenograft (PDX) organoids without compromising structural integrity
• Scalable electroporation process mapping for IND-enabling studies (e.g., DOE-driven optimization of voltage/pulse number/timing)
• High-content screening of gene-editing efficiency using integrated live-cell imaging-compatible workflows

FAQ

Is the ExTransfection™ compatible with single-cell RNA sequencing (scRNA-seq) sample preparation?
Yes—the capillary chamber minimizes cellular aggregation and preserves transcriptome integrity; recommended protocols include immediate post-electroporation lysis or cryopreservation in RNAlater-compatible buffers.
Can I import custom pulse waveforms (e.g., exponential decay, square wave, multi-phase) into the system?
Yes—advanced users may define custom waveforms via the Developer Mode interface, subject to hardware safety limits (max 1200 V, 50 ms total pulse width, ≤5 pulses per cycle).
Does the system support Good Manufacturing Practice (GMP) documentation packages for clinical trial material production?
Yes—NanoEntek offers IQ/OQ/PQ validation kits, URS templates, and 21 CFR Part 11 compliance add-ons for qualified users engaged in ATMP development.
What is the maximum recommended cell concentration for capillary loading?
Optimal range is 1 × 10⁶ to 1 × 10⁷ cells/mL in final electroporation mixture; higher densities increase impedance variability and reduce reproducibility.
How frequently does the capillary chamber require replacement?
Under standard usage (≤10 runs/day), the fused-silica capillary is rated for ≥500 cycles; replacement is indicated when baseline impedance deviates by >15% from factory calibration or visible microfractures appear under 10× magnification.